about
sameAs
Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South AfricaCorrection: Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South AfricaFactors associated with increased mortality in a predominantly HIV-infected population with Stevens Johnson syndrome and toxic epidermal necrolysisStevens Johnson Syndrome and Toxic Epidermal Necrolysis: Maternal and Foetal Outcomes in Twenty-Two Consecutive Pregnant HIV Infected WomenClinical presentations of severe cutaneous drug reactions in HIV-infected Africans.A dimorphic fungus causing disseminated infection in South Africa.Transcriptional profiling of innate and adaptive human immune responses to mycobacteria in the tuberculin skin test.In Vivo Molecular Dissection of the Effects of HIV-1 in Active Tuberculosis.Lichenoid drug reaction to antituberculosis drugs treated through with topical steroids and phototherapy.Case Report: Stevens-Johnson syndrome following a single double dosing of nevirapine-containing regimen once in an HIV-infected woman on long-term antiretroviral therapy.Dermatologic manifestations of the immune reconstitution inflammatory syndrome.Annular erythema and photosensitivity as manifestations of efavirenz-induced cutaneous reactions: a review of five consecutive cases.Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future.Clinical Characteristics, Diagnosis, Management, and Outcomes of Disseminated Emmonsiosis: A Retrospective Case Series.Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.Impact of correcting the lymphocyte count to improve the sensitivity of TB antigen-specific peripheral blood-based quantitative T cell assays (T-SPOT.(®)TB and QFT-GIT).Severe antiretroviral-associated skin reactions in South African patients: a case series and case-control analysis.Therapeutic Trial of Rifabutin After Rifampicin-Associated DRESS Syndrome in Tuberculosis-Human Immunodeficiency Virus Coinfected Patients.Diagnostic patch testing following tuberculosis-associated cutaneous adverse drug reactions induces systemic reactions in HIV-infected persons.Multiple drug hypersensitivity reactions to anti-tuberculosis drugs: five cases in HIV-infected patients.Lack of cross-toxicity between isoniazid and ethionamide in severe cutaneous adverse drug reactions: a series of 25 consecutive confirmed cases.Severe recurrence of drug rash with eosinophilia and systemic symptoms syndrome secondary to rifampicin patch testing in a human immunodeficiency virus-infected man.Sweet syndrome: adverse drug reaction or novel manifestation of HIV-associated immune reconstitution inflammatory syndrome?Incidence of anxiety and depression in a predominantly HIV-infected population with severe adverse drug reactions.Folliculitis keloidalis nuchae is associated with the risk for bleeding from haircuts.AIDS-Related Endemic Mycoses in Western Cape, South Africa, and Clinical Mimics: A Cross-Sectional Study of Adults With Advanced HIV and Recent-Onset, Widespread Skin Lesions.Cutaneous adverse drug reactions caused by FDCAs - we need to characterise and manage them urgently.Immune Mechanisms of Drug AllergyFaculty of 1000 evaluation for China cracks down after investigation finds massive peer-review fraudFaculty of 1000 evaluation for The pressure to publish pushes down qualityFaculty of 1000 evaluation for Immune-mediated reactions to vancomycin: A systematic case review and analysisFaculty of 1000 evaluation for Mortality among MDR-TB Cases: Comparison with Drug-Susceptible Tuberculosis and Associated FactorsFaculty of 1000 evaluation for Loss from treatment for drug resistant tuberculosis: risk factors and patient outcomes in a community-based program in khayelitsha, South AfricaFaculty of 1000 evaluation for Development and evaluation of a pilot nurse case management model to address multidrug-resistant tuberculosis (MDR-TB) and HIV in South AfricaFaculty of 1000 evaluation for Adverse drug reactions in dermatologyFaculty of 1000 evaluation for Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: Survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR)Faculty of 1000 evaluation for Where should I send it? Optimizing the submission decision processFaculty of 1000 evaluation for Low Resistance to First and Second Line Anti-Tuberculosis Drugs among Treatment Naive Pulmonary Tuberculosis Patients in Southwestern UgandaToxic epidermal necrolysis with failure of re-epithelialization. Could umbilical cord mesenchymal stem cell transplantation have a role?Aggressive worsening of Sézary syndrome during early antiretroviral therapy
P50
Q28487731-62DBD4A2-7C2A-4260-808C-DCE48427BC3DQ28533564-0805A2B8-29E0-4F84-A795-75892BDB222FQ28541785-A45BEC81-1D6E-4280-96FE-31D2586EAB3EQ28547203-F716098F-1974-478D-A269-6BAB8E55C3D1Q30360751-489094B4-D892-4D10-96C7-2702C0B9E38AQ30672930-58E1304E-52F4-4C72-BE2B-63F65B8ED9A6Q35673474-BD358C5F-0344-4F74-B502-ED942069CEBFQ35960979-19D2A06D-99B6-4920-A44D-0FD46CB41D6BQ36239529-180E00F4-4F1A-4327-8C82-E6C97DD6BB53Q36274484-A87EDC98-24CC-46A5-8796-C68CD277C942Q36608014-E37CE6C4-CF2C-4E90-9E68-12FAF061F3D8Q37463268-C5D9351C-3AE4-4A3C-9ADD-45EF3D2A4844Q38003494-2F6A4CE9-026D-4354-A775-AED2F0941F1EQ38523245-549DD66E-EF74-4D74-9392-676E909684C2Q39291741-54992404-C0C3-4988-A538-7834CE82D2BBQ39433439-3BA8B9B5-38FC-4443-ABD5-00980AE9F14FQ39553824-C7B5DA76-1A84-4A45-A746-33938ED2E4D7Q39599358-87365FF9-BD35-4C33-A8F6-F8B7E0721A58Q39966338-0668E6D8-D5CD-448F-AAD3-8109529ADFF9Q40281821-A6464A46-57A1-4398-8935-47FD066AA070Q41123359-609E921B-A3E1-4655-B89F-AE2E4F2D32ACQ42241921-267F08BA-2464-4045-8689-D172BB295D40Q44168530-A7EF5D8E-D178-4CF7-B402-27E934F15BCFQ46067120-18B9C662-ED73-4155-A193-302186B1146FQ46245880-74289AFA-3C42-4C88-9C80-DA60ADCE11D8Q46256434-696E1984-AEC0-409B-BCDA-DFDDF3CFC20FQ46605001-42D1A7F2-4FC3-4A1D-8458-A30778BE702BQ59112363-FCC9CF2A-56FA-47B3-80B8-820E9DE61569Q59112367-1AB3494E-6B34-48B3-99E2-374AE8199345Q59112378-6A0EBCB6-591D-4AB6-9B95-AB696F485F80Q59112387-F0A14980-10FD-4090-BB77-5987F7B5611AQ59112409-B57D31D3-A5C3-4F75-8700-0E7FD2599E86Q59112415-EA0DEEAF-63D7-4E23-B3B9-0894987F4764Q59112419-1AE4E4AC-499E-4551-8C40-694C0AEE8648Q59112425-56975513-19E8-4672-89A0-BED575BC4443Q59112430-3732951A-0A65-41C5-97D6-8D3D753A9735Q59112435-DF0B027B-BD72-4DBF-B62A-CDDA1991733EQ59112440-EA117FE9-59BE-423A-889C-B342EAA0705AQ59112468-A044233C-B602-499F-A8E7-0EA1281D4BC5Q59112474-9852DD11-823B-4038-AEA0-ABFC9CCA5AC2
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rannakoe Lehloenya
@ast
Rannakoe Lehloenya
@en
Rannakoe Lehloenya
@es
Rannakoe Lehloenya
@nl
Rannakoe Lehloenya
@sl
type
label
Rannakoe Lehloenya
@ast
Rannakoe Lehloenya
@en
Rannakoe Lehloenya
@es
Rannakoe Lehloenya
@nl
Rannakoe Lehloenya
@sl
altLabel
Ranks
@en
Rannakoe J Lehloenya
@en
prefLabel
Rannakoe Lehloenya
@ast
Rannakoe Lehloenya
@en
Rannakoe Lehloenya
@es
Rannakoe Lehloenya
@nl
Rannakoe Lehloenya
@sl
P1053
C-5672-2012
P106
P21
P31
P3829
P496
0000-0002-1281-1789